| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SREP05855 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/srep05855 |
| P932 | PMC publication ID | 5376169 |
| P698 | PubMed publication ID | 25068480 |
| P50 | author | Song-hua Fan | Q85510266 |
| P2093 | author name string | Qi Li | |
| Peng Xie | |||
| Zhao Liu | |||
| Peng Zheng | |||
| Jun Mu | |||
| Jian-jun Chen | |||
| De-yu Yang | |||
| Yong-tao Yang | |||
| Wei-hua Shao | |||
| Xue-jiao Xu | |||
| Zhi-guo Qi | |||
| P2860 | cites work | Systems biology: Metabonomics | Q47647280 |
| Plasma metabonomics as a novel diagnostic approach for major depressive disorder. | Q48760949 | ||
| 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. | Q50663896 | ||
| Dual activation of GABAA and glycine receptors by beta-alanine: inverse modulation by progesterone and 5 alpha-pregnan-3 alpha-ol-20-one. | Q51658369 | ||
| Metabolome Analysis | Q57020658 | ||
| OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification | Q58045925 | ||
| Nuclear Magnetic Resonance Spectroscopic and Principal Components Analysis Investigations into Biochemical Effects of Three Model Hepatotoxins | Q58046285 | ||
| Bipolar disorder | Q77549686 | ||
| A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats | Q80037913 | ||
| 1H-NMR-based metabolomics study of cerebral infarction | Q83809378 | ||
| More good news about the magic ion: lithium may prevent dementia | Q83985690 | ||
| The human urine metabolome | Q21132532 | ||
| MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis | Q24632755 | ||
| Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder | Q30448885 | ||
| Analysis of metabolomic data using support vector machines | Q33366103 | ||
| Thalamic transcriptome screening in three psychiatric states | Q33510901 | ||
| Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative | Q34026000 | ||
| Metabolomics: a global biochemical approach to drug response and disease | Q34734298 | ||
| Urinary metabolite markers of precocious puberty | Q35722258 | ||
| Pyrimidine pathways in health and disease | Q36228595 | ||
| Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder | Q36400018 | ||
| Potential metabolite markers of schizophrenia. | Q36479055 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors? | Q36556737 | ||
| Metabonomics study of essential hypertension and its chinese medicine subtypes by using gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy | Q36682631 | ||
| Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. | Q36936018 | ||
| Oxidative stress markers in bipolar disorder: a meta-analysis | Q37186196 | ||
| Neurological disorders of purine and pyrimidine metabolism | Q37852735 | ||
| Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics | Q39934894 | ||
| Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis | Q41952903 | ||
| Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls | Q43119044 | ||
| Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results | Q43760767 | ||
| A novel urinary metabolite signature for diagnosing major depressive disorder | Q43827823 | ||
| Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. | Q45222765 | ||
| Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy. | Q46478771 | ||
| Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder | Q46767416 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| biomarker | Q864574 | ||
| P304 | page(s) | 5855 | |
| P577 | publication date | 2014-07-28 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder | |
| P478 | volume | 4 |
| Q42160741 | 1H NMR-based Investigation of Metabolic Response to Electro-Acupuncture Stimulation |
| Q35585693 | 1H NMR-based metabolic profiling reveals the effects of fluoxetine on lipid and amino acid metabolism in astrocytes. |
| Q93167649 | Age-specific urinary metabolite signatures and functions in patients with major depressive disorder |
| Q57284977 | Combining Mass Spectrometry and NMR Improves Metabolite Detection and Annotation |
| Q28546284 | Comparative Metabolomic Analysis of the Neuroprotective Effects of Scutellarin and Scutellarein against Ischemic Insult |
| Q35683830 | Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial |
| Q64091668 | Comparison of the Proximate Composition, Vitamins (Ascorbic Acid, α-Tocopherol and Retinol), Anti-Nutrients (Phytate and Oxalate) and the GC-MS Analysis of the Essential Oil of the Root and Leaf of L |
| Q89507956 | Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study |
| Q38830302 | Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis |
| Q37398383 | Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies |
| Q53432505 | Elucidating time-dependent changes in the urinary metabolome of renal transplant patients by a combined (1)H NMR and GC-MS approach. |
| Q37648213 | Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics |
| Q64263238 | Impact of phytosterols on liver and distal colon metabolome in experimental murine colitis model: an explorative study |
| Q64258063 | Integrated Proteomics and Metabolomic Analyses of Plasma Injury Biomarkers in a Serious Brain Trauma Model in Rats |
| Q47642189 | Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers |
| Q90341474 | Metabolomics Biomarkers for Precision Psychiatry |
| Q33704082 | Novel urinary metabolite signature for diagnosing postpartum depression |
| Q52879696 | Omega-3 Fatty acids as Monotherapy in Treating Depression in Pregnant Women: a Meta- Analysis of Randomized Controlled Trials. |
| Q94560655 | Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis |
| Q37200180 | Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder. |
| Q36500840 | Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention |
| Q58591209 | Predictive Role of Urinary Metabolic Profile for Abnormal MRI Score in Preterm Neonates |
| Q39096252 | Recent Advances in NMR-Based Metabolomics |
| Q49332592 | Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment. |
| Q34757521 | Sex-specific urinary biomarkers for diagnosing bipolar disorder |
| Q26769944 | Urinary Biomarkers of Brain Diseases |
| Q57155162 | Urinary biomarker panel for diagnosing patients with depression and anxiety disorders |
| Q93185341 | Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus |
| Q64262134 | Urinary metabolite signature in bipolar disorder patients during depressive episode |
| Q35645024 | Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients |
Search more.